atazanavir mylan
mylan pharmaceuticals limited - atazanavir (as sulfate) - hiv infections - antivirals for systemic use - atazanavir mylan, co-administered with low dose ritonavir, is indicated for the treatment of hiv 1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors (≥ 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years.the choice of atazanavir mylan in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient’s treatment history.
atazanavir viatris
viatris limited - atazanavir sulfate 170.85mg equivalent to atazanavir 150mg; atazanavir sulfate 170.85mg equivalent to atazanavir 150mg - capsule - 150 mg - active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: crospovidone gelatin iron oxide red lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: brilliant blue fcf crospovidone erythrosine gelatin iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir viatris
viatris limited - atazanavir sulfate 227.8mg equivalent to atazanavir 200mg; atazanavir sulfate 227.8mg equivalent to atazanavir 200mg - capsule - 200 mg - active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: brilliant blue fcf crospovidone erythrosine gelatin lactose monohydrate magnesium stearate purified water titanium dioxide active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: crospovidone gelatin indigo carmine iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
atazanavir viatris
viatris limited - atazanavir sulfate 341.7mg equivalent to atazanavir 300mg; atazanavir sulfate 341.7mg equivalent to atazanavir 300mg - capsule - 300 mg - active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: brilliant blue fcf crospovidone erythrosine gelatin iron oxide red iron oxide yellow lactose monohydrate magnesium stearate purified water titanium dioxide active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: crospovidone gelatin iron oxide red iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water tekprint black sw-9008 titanium dioxide - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.
mylan-atazanavir capsule
mylan pharmaceuticals ulc - atazanavir (atazanavir sulfate) - capsule - 150mg - atazanavir (atazanavir sulfate) 150mg - hiv protease inhibitors
mylan-atazanavir capsule
mylan pharmaceuticals ulc - atazanavir (atazanavir sulfate) - capsule - 200mg - atazanavir (atazanavir sulfate) 200mg - hiv protease inhibitors
mylan-atazanavir capsule
mylan pharmaceuticals ulc - atazanavir (atazanavir sulfate) - capsule - 300mg - atazanavir (atazanavir sulfate) 300mg - hiv protease inhibitors
atazanavir myl atazanavir (as sulfate) 300 mg capsule bottle
alphapharm pty ltd - atazanavir sulfate -
atazanavir myl atazanavir (as sulfate) 200 mg capsule bottle
alphapharm pty ltd - atazanavir sulfate -
anzavir-r tablets modified-release tablet
mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d centre plot no. - atazanavir sulfate equivalent to atazanavir - modified-release tablet - atazanavir sulfate equivalent to atazanavir 300mg - antivirals for systemic use: protease inhibitors